Abbott, Reckitt face new trial over premature infant formula
Reckitt said on Friday a circuit court in the United States had ruled that a new trial could be sought by plaintiffs in a ...
GlobalData on MSN7d
Reckitt still assessing options for Mead Johnson infant-formula “exit”
CEO Kris Licht said last week that Reckitt has received “interest” from prospective buyers for its nutrition unit housing ...
Baby Formula Makers Abbott and Reckitt See Stocks Slide as Judge Allows Retrial
Infant formula makers Abbott and Reckitt saw their stocks decline Friday after a judge ruled plaintiffs could pursue a new ...
In a setback for Abbott Laboratories, judge allows new trial in case over formula for premature infants
The decision to allow a new trial could have  implications for both the companies and families with babies born prematurely.
Crain's Chicago Business2d
That baby formula trial Abbott and Reckitt won isn't over just yet
Back in October, a jury found North Chicago-based Abbott and Reckitt’s formula subsidiary Mead Johnson not responsible for a ...
Reuters11d
Strepsils maker Reckitt misses sales forecast on late flu season, but lower costs help
Reckitt has had a mixed year, with its stock falling sharply early on in 2024 over an internal investigation into its Middle ...
Reckitt Shares Drop on Infant Formula Retrial in U.S.
Reckitt--which houses Dettol, Harpic and Durex among its brands--said the judge ordered a retrial of a Missouri lawsuit that had found in October that subsidiary Mead Johnson wasn't liable for ...
Citi sees overturned verdict in state case as incrementally negative for Abbott
Citi notes that Investing.com reported on Friday that the judge in the Whitfield infant formula case has overturned the October 31 verdict, ...